UNIVERCELLS
Holdings
own 2023 accountsThis companyUNIVERCELLS6 holdings, 2 countries
2023 accounts
Belgium 5 Year Equity Result
- BE open bankruptcy 2023€5.3m result -€3.0m (2023)
- BE open bankruptcy 2023€4.6m result -€31.4m (2023)
- BE 2025€73,460 result -€126,289 (2025)
- BE 2023€52,468 result -€35,527 (2023)
- BE open bankruptcy 2023-€1.2m result -€14.2m (2023)
Europe 1 Year Equity Result
- FR 2023€8.4m result -€5.1m (2023)
Source: list of holdings in its own 2023 accounts. Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.
Holdings and subsidiaries
6 holdingsHoldings 6
Share, source and own figures per holding (6)
Source for every holding own accounts 2023
- subsidiaryEquity €4.6m Loss of €31.4m in 2023 (loss of €23.0m in 2022) Checked score100%
- subsidiaryEquity -€1.2m Loss of €14.2m in 2023 (loss of €11.6m in 2022) Checked score100%
- subsidiaryEquity €52,468 Loss of €35,527 in 2023 (loss of €103,505 in 2022)100%
- FRsubsidiaryEquity €8.4mResult -€5.1m100%
- subsidiaryEquity €73,460 Loss of €126,289 in 2025 (loss of €166,783 in 2024) Checked score100%
- subsidiaryEquity €5.3m Loss of €3.0m in 2023 (loss of €4.7m in 2022) Checked score100%
Board mandates elsewhere
1 board mandateBoard mandates of UNIVERCELLSUNIVERCELLS sits on their board1
Director
Founded in 2021 · total assets €8.6m (2024) · accounts filed late
Acquisitions and mergers
5 transactionsReceived in a demerger part of:Quantoom Biosciences
Contributed a branch of activity to:Univercells Vaccines
Contributed a branch of activity to:EXOTHERA
Contributed a branch of activity to:AD SANITAS
Contributed a branch of activity to:UNIGAMMA
Connections & network
3 last directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.